Abstract: An accommodating intraocular lens (IOL) can be implanted either alone or as part of a two-part lens assembly. The IOL comprises an optic, a flexible membrane and a peripheral edge coupling the optic and the flexible membrane. The peripheral edge comprises an external circumferential surface having a height and a force transmitting area defined along a portion of the height of the external circumferential surface. A closed volume spaces apart the optic and the flexible membrane. The optic is axially displaced and the flexible membrane changes in curvature about a central axis when a radial compressive force is applied to the force transmitting area. A volume defined by the closed volume remains fixed when the optic is axially displaced and the flexible membrane changes in curvature and/or when the radial compressive force is applied to the force transmitting area.

Abstract: An exchangeable lens platform (ELP) comprises a horseshoe-shaped ring structure, which has a memory strip incorporated therein, into which the haptic end components of the intraocular lens (IOL) can engage diametrically opposite portions of the ring structure. In this manner, the exchangeable lens platform (ELP) can not only be opened or expanded so as to be disposed within any sized capsular bag in a secure and stabilized manner, but diametrically opposite portions of the exchangeable lens platform (ELP) can effectively fold upon themselves such that the exchangeable lens platform (ELP) will effectively be partially folded in half such that the diametrically opposite folded portions of the exchangeable lens platform (ELP) can effectively engage diametrically opposed internal wall portions of the fornix of the capsular bag so as to permit the intraocular lens (IOL) to then be properly centered, oriented, stabilized, and secured within the eye.

Abstract: A method of inserting an ocular implant into Schlemm's canal, the method comprising: moving the ocular implant into Schlemm's canal; and injecting a visco-elastic medium in front of the implant.

Abstract: A system and method for inserting an intraocular lens in a patient's eye includes a light source for generating a light beam, a scanner for deflecting the light beam to form an enclosed treatment pattern that includes a registration feature, and a delivery system for delivering the enclosed treatment pattern to target tissue in the patient's eye to form an enclosed incision therein having the registration feature. An intraocular lens is placed within the enclosed incision, wherein the intraocular lens has a registration feature that engages with the registration feature of the enclosed incision. Alternately, the scanner can make a separate registration incision for a post that is connected to the intraocular lens via a strut member.

Abstract: Described herein are dehydrated, laminated tissue grafts composed of two or more membrane layers of an amnion membrane, a chorion membrane, a Wharton's jelly, or an intermediate tissue layer, where a layer of micronized placental tissue is interposed between two of the layers. Also described herein are methods for making and using the laminated tissue grafts.

Abstract: Hybrid Accommodating Intra Ocular Lens (AIOL) assemblages including two discrete component parts in the form of a discrete base member for initial implantation in a vacated capsular bag and a discrete lens unit for subsequent implantation in the vacated capsular bag for anchoring to the discrete base member. The lens unit includes a lens optics having at least two lens haptics radially outwardly extending therefrom. The base member includes a flat circular base member centerpiece having zero optical power.

Abstract: A host computing system may include a processor and a memory coupled to the processor. The memory may include an auto-discovery module to broadcast a message to a set of management nodes in a data center. The message may include a configuration policy. Further, the auto-discovery module may receive an acknowledgment message from a management node. The acknowledgment message may indicate that the management node supports the configuration policy. Furthermore, the auto-discovery module may establish a trust relationship with the management node in response to receiving the acknowledgment message. Further, the auto-discovery module may enable the host computing system to add to a cluster managed by the management node upon establishing the trust relationship.

Abstract: An ophthalmic lens system for reducing the risk of progression of a myopic eye by selectively maintaining, inducing or creating asymmetry of the peripheral retinal profile for the eye. A method for reducing the risk of progression of myopia comprising determining the magnitude of asymmetry of the on-axis/off-axis refractive error profile or eye length profile of the eye and providing an ophthalmic lens system that corrects for and provides acceptable on-axis vision and simultaneously controls the position of the off-axis refractive error profile or eye length profile such that resultant profile of the eye is asymmetric.

Abstract: Reversibly deformable corneal implants for replacing excised corneal tissue, the implants including an optical portion and an anchoring portion having different mechanical properties from each other.

Abstract: An injector (1) for implanting a sensor implant (2) in the human or animal eye, in particular for the suprachoroidal implantation of a pressure sensor for the wireless measurement of the intraocular pressure, is improved in terms of rapid, complication-free, low-trauma and low-wear suprachoroidal implantation in that, to accommodate the sensor implant, the injector (1) has a substantially tubular injection chamber (8), the inner wall surfaces (9, 10) of which have a non-rotationally symmetrical cross section, preferably an oval or rectangular cross section, in that, at a free end, the injection chamber (8) is provided with an injection opening (13), through which, during implantation, the sensor implant (2) can slide out and slide into a sclera incision in the eye, wherein the inner wall surfaces (9, 10) of the injection chamber (8) enclose the likewise non-rotationally symmetrical cross section of the sensor implant (8) and prevent a rotation of the sensor implant (2) about an axis of rotation extending in t

Abstract: A system and method of customizing at least one characteristic for an intraocular lens include includes measuring at least one biometric parameter of an eye simulating a corneal spherical aberration and an anterior chamber depth of the eye, and empirically calculating a post-operative spherical aberration at an iris or pupil plane of the eye, based on a regression formula including the corneal spherical aberration, the anterior chamber depth, and the biometric parameter(s), in order to obtain a desired postoperative condition.

Abstract: An intraocular brain interface system that detects a user's neuronal activity and uses it to identify an image associated with that neuronal activity. Once identified, the image is presented to the user via an intraocular display component such that only the user is able to see the image.

Abstract: A tactile sensation providing method and device. The tactile sensation providing method includes: generating a first tactile sensation based on information of a contour attribute of a visual object; generating a second tactile sensation based on information of a texture attribute of the visual object; and generating a third tactile sensation based on information of a roughness attribute of the visual object.

Abstract: The present invention includes a device for effecting deformation of a sclera of an eye, including an expandable, mesh tube having holes dispersed through an entire surface thereof and with first and second tapered ends, and inserted unexpanded to deform the sclera when expanded. A central portion is intrascleral, with the first and second tapered ends external to the sclera on top of an intact scleral surface to deform during expansion, and simultaneously causes the sclera to be deformed so that the sclera moves towards the inside of the eye while simultaneously causing the sclera to move towards the outside of the eye. The mesh tube includes struts, connecting points of the struts are of different sizes, the first and second tapered ends and the connecting points within the tapered ends are thicker than the connecting points of the mesh tube, and the mesh tube includes fixation tabs.

Abstract: A device for implantation into an eye for supporting an intraocular lens during and following surgery. The device may include a ring and at least one support. The ring may have an open portion defined between a first eyelet on a first end and a second eyelet on a second end, the ring being radially compressible. The at least one support may be defined internally of the ring and have a position on which a lens is nestably engaged with the at least one support above a tear in the capsular bag of the eye.

Abstract: An orbital tissue retractor 10 for use in a surgical operation in the region of an eye socket, comprises an orbital tissue retractor body 12 and a handle 14 extending therefrom for manipulation of the tissue retractor body by a surgeon. The tissue retractor body comprises a channel formation 16 defining a channel 17. The channel formation 16 has a pair of spaced side wall sections 24 which define concave curved ocular abutment formations 26 which conform to an anatomical curvature of the ocular globe for abutment with the ocular globe N. The tissue retractor body has open proximal end 22 and an open distal end 20. The tissue retractor body tapers from the proximal end to the distal end, with a portion of the channel formation at the distal end being curved so as to accommodate and cradle the optic nerve therein. The retractor body has a curved base wall section 28 conforming to an anatomical curvature of the orbit.

Abstract: A modular transdermal drug delivery system is provided, the system including: an upper module in which an outer backing layer is laminated to a pressure-sensitive adhesive layer that is covered by a removable release liner prior to assembly; and a lower module with a porous drug reservoir layer laminated to a skin-contact adhesive that affixes the system to the skin during drug delivery, where the skin-contact adhesive is, in one embodiment, an adhesive layer that is substantially co-extensive with the porous drug reservoir layer and, prior to use, protected with a second removable release liner. Methods of manufacture and use are also provided, as is an assembled transdermal drug delivery system fabricated by affixing the pressure-sensitive adhesive layer of the upper module to the porous drug reservoir layer of the lower module.

Abstract: A smart body analyzer apparatus includes a rotatable plate for supporting and turning a body, a control unit for rotating the rotatable plate, and at least one group of touch-less sensors for scanning the body. Examples of touch-less sensors include a far infrared temperature sensor and a depth sensor. The depth sensor can employ a time-of-flight imaging method, a stereoscopic imaging method, a microwave imaging method and/or a laser ranging method based on trigonometric principles.

Abstract: A scanning system is providing including a scanner and a scan crutch. The scanner includes a housing, a window in an upper end of the housing, and a light emitter/receiver in the housing under the window. The scan crutch is attached to the scanner and includes a base and a protrusion extending from the base in a direction away from the scanner. The protrusion of the scan crutch ensures accurate and repeatable scanning of target objects by allowing a user to quickly position the scanner at an optimum distance from a target object by contacting the target object with the protrusion of the scan crutch.

Abstract: Systems and methods for treating ocular disorders are disclosed. One system has a delivery instrument, with a non-linear axis, configured to be inserted into an anterior chamber of an eye and moved to a location proximate a physiologic outflow pathway of the eye. The delivery instrument carries an implant that has a distal end sized for insertion into tissue such that aqueous humor drains from the anterior chamber to the physiologic outflow pathway. One method involves inserting a non-linear portion of a delivery device into the anterior chamber to position an implant within the eye. Another method involves using a delivery device with a curved distal portion to implant an implant at a location communicating with the physiologic outflow pathway. The delivery can be through a corneal incision and the implant can comprise a drug.

Abstract: An IOL system includes a capsular ring having a concave exterior surface extending around its circumference that is configured, upon insertion into a capsular bag of a patient's eye, to engage an equatorial region of the capsular bag. The concave exterior surface extends between an anterior surface and a posterior surface of the capsular ring. A first one or more flaps are arranged on the anterior surface such that at least a portion of each of the first one or more flaps, upon insertion into the capsular bag of a patient's eye, engages an anterior portion of the capsular bag. Similarly, a second one or more flaps are arranged on the posterior surface such that at least a portion of each of the second one or more flaps, upon insertion into a capsular bag of a patient's eye, engages a posterior portion of the capsular bag.

Abstract: A scleral belt with an elongate strap having a first end and a second end. The strap has a plurality of openings disposed near the first end. A loop is disposed near the second end of the strap. A frame may be pivotally attached at the second end. The frame supports a prong which is pivotally attached to the frame. The first end of the strap passes through the frame and the loop, and the prong engages with one of the openings to fix the position of the two ends of the strap. The operation of the improved scleral belt makes it easier to adjust the scleral belt to adjust the height and location of the “buckling effect.

Abstract: The present invention relates generally to the fields of ophthalmology and cataract surgery. More specifically, the present invention relates to a device implanted in the eye during cataract surgery and improves the optical functionality of the eye. This invention is in the field of medical devices and relates to capsular tension rings that are designed to be implanted in the capsular sac after removal of the crystalline lens affected by a cataract in association with an intraocular lens designed to replace the crystalline lens. The invention applies to stabilizing the artificial lens from movement in the x-y-z planes and prevents rotation.

Abstract: Intraocular apparatus is provided, having an anterior side and a posterior side, and configured for use with an extraocular imaging device. The intraocular apparatus includes a photovoltaic energy receiver, or an RF energy receiver, on the anterior side which receives energy from outside the eye to power the intraocular apparatus. Additionally, the intraocular apparatus includes a photodiode on the anterior side of the intraocular apparatus which receives data from the extraocular imaging device. An application-specific-integrated-circuit (ASIC) is positioned on the posterior side of the intraocular apparatus and includes (i) circuitry configured to process the data from the photodiode into an image, (ii) an electronic display, e.g., a light-emitting diode (LED) display, which emits light representing the image, and (iii) at least two through-silicon vias connecting the ASIC to the photovoltaic energy receiver and to the photodiode. Other applications are also described.

Abstract: A display device is mounted on and/or inside the eye. The eye mounted display contains multiple sub-displays, each of which projects light to different retinal positions within a portion of the retina corresponding to the sub-display. The projected light propagates through the pupil but does not fill the entire pupil. In this way, multiple sub-displays can project their light onto the relevant portion of the retina. Moving from the pupil to the cornea, the projection of the pupil onto the cornea will be referred to as the corneal aperture. The projected light propagates through less than the full corneal aperture. The sub-displays use spatial multiplexing at the corneal surface. Various electronic devices interface to the eye mounted display.

Abstract: The present invention includes a device for effecting deformation of a sclera of an eye, including an expandable, mesh tube having holes dispersed through an entire surface thereof and with first and second tapered ends, and inserted unexpanded to deform the sclera when expanded. A central portion is intrascleral, with the first and second tapered ends external to the sclera on top of an intact scleral surface to deform during expansion, and simultaneously causes the sclera to be deformed so that the sclera moves towards the inside of the eye while simultaneously causing the sclera to move towards the outside of the eye. The mesh tube includes struts, connecting points of the struts are of different sizes, the first and second tapered ends and the connecting points within the tapered ends are thicker than the connecting points of the mesh tube, and the mesh tube includes fixation tabs.

Abstract: A system for measuring microfluctuation of accommodation comprises a measuring module and a processing module. The measuring module includes at least one first sensing element attached to the area around an eye of a testee for measuring an EMG signal. The processing module is coupled with the measuring module for picking up a specific frequency range of the EMG signal as a measurement index of microfluctuation of accommodation, wherein the specific frequency range is between 0.1 Hz and 100 Hz. The system allows the testee to be tested in an open field of view and exempts the testee from experiencing fatigue in the muscle around the eyes. The system is compact and convenient to carry. A method for measuring microfluctuation of accommodation is also disclosed.

Abstract: Intraocular pressure can be reduced by insertion of an intraocular shunt in the eye such that it forms a drainage pathway between the anterior chamber and a region of lower pressure. A hollow shaft that holds an intraocular shunt can be advanced through the anterior chamber. The sclera can be penetrated with the hollow shaft. A beveled tip of the shaft can be oriented such that a beveled surface thereof faces toward the Tenon's capsule when the beveled tip passes out of the sclera. After the beveled tip passes out of the sclera, at least a portion of the shunt can be advanced from the hollow shaft.

Abstract: Embodiments of an intraocular lens are described. The intraocular lens includes a lens having a center and having positive or negative optical power and a pinhole mask formed on the lens. The pinhole mask includes one or more annular sections whose centers substantially coincide with the center of the lens, each of the one or more concentric annular sections having variable opacity, and a central section that is permanently transparent, the radius of the central section being adapted to allow the central section to act as a pinhole when the one or more concentric annular sections are made opaque.

Abstract: A scleral prosthesis includes an elongated body having a first free end and a second free end opposite the first free end. A maximum width of the body at each end is wider than a maximum width of the body between the ends. The body includes multiple first portions that form the first free end of the body and a part of the body between the ends. The first portions are separated lengthwise along a substantial portion of a total length of the body. The first portions of the body are biased so that they maintain separation from one another without external interference but are configured to be pushed towards each other. The body is configured to receive and retain, between the first portions of the body, an insert that is configured to maintain the separation of the first portions.

Abstract: The present invention relates generally to the restoration or improvement of the quality of human vision and, more particularly to a self-adapting system and method for achieving automatic sharp vision by the human eye of objects for instance at distances between 25 cm and more than 10 meters away. The invention can be situated in at least four technological domains: 1. ophthalmology, in particular the implantation of intraocular lenses. 2. Non-contact biometric signal recording and processing. 3. Electro-optic control of refractive lens power. 4. Wireless energy transfer.

Abstract: A system and method for designing scleral lenses includes a computer, a camera and a lathe connected by a network. The camera captures a set of sagittal images at each of a set of sagittal planes of an eye. A combined sagittal image is created from each set of sagittal images. A spline curve is defined for each combined sagittal image creating a set of spline curves. A set of back surface curves is created from the set of spline curves. A back lens surface is generated from the set of surface curves. A front lens surface is generated adjacent the back lens surface. A point cloud is generated from the back lens surface and the front lens surface. The point cloud is converted to a lens image. The lens is converted to a text file for use by the lathe to cut the scleral lens.

Abstract: Glaucoma can be treated by implanting an intraocular shunt into an eye. The eye has an anterior chamber and sclera. A shunt can be placed into the eye to establish fluid communication from the anterior chamber of the eye through the sclera, and a pharmaceutical or biological agent can be administered to the eye.

Abstract: Contact lenses incorporate multifocal power profiles that at least one of slow, retard or preventing myopia progression. The lens includes a first zone at a center of the ophthalmic lens and at least one peripheral zone surrounding the first zone. The at least one peripheral zone has a different width and dioptric power than the first zone. The first zone and at least one peripheral zone are stepped or discontinuous. The multifocal power profile has substantially equivalent foveal vision correction to a single vision lens and has a depth of focus and reduced retinal image quality sensitivity that slows, retards, or prevents myopia progression.

Abstract: An intraocular lens includes a lens capsule expanding device and an optical portion. A front supporting portion makes contact with an inner surface of an anterior capsule. A rear supporting portion makes contact with an inner surface of a posterior capsule while facing the front supporting portion. A connecting portion connects the front supporting portion and the rear supporting portion so as to have a biasing force to separate the front supporting portion and the rear supporting portion. Due to the biasing force, the front supporting portion presses the inner surface of the anterior capsule and the rear supporting portion presses the inner surface of the posterior capsule. The optical portion changes the curvature of a central portion according to movement of the connecting portion that moves the front supporting portion and the rear supporting portion closer to or away from each other with movement of the lens capsule.

Abstract: The present invention includes a device and method for treatment of retinal detachment, ocular hypertension and glaucoma, and increasing an amplitude of accommodation. The device includes a tapered, mesh tube that within a sclera, expands to deform the sclera, and when placed within the posterior sclera for the treatment of a retinal tear, the device expands deforming the sclera so that the retinal pigment epithelium comes in contact with the retinal tear to seal the tear. For the treatment of ocular hypertension, glaucoma and to increase the amplitude of accommodation, the device is placed within the anterior sclera over the posterior plicata of the ciliary body, which upon expansion causes the underlying ciliary body to deform, resulting in traction on the trabecular meshwork and deformation of the ciliary body, which causes lowering of intraocular pressure, and increases the amplitude of accommodation in patients with ocular hypertension or decreased accommodation.

Abstract: Glaucoma can be treated by implanting an intraocular shunt into an eye. The eye has an anterior chamber and sclera. A shunt can be placed into the eye to establish fluid communication from the anterior chamber of the eye through the sclera.

Abstract: The invention provides new crystalline forms of 7-[3,5-Dihydroxy-2-(3-hydroxy-5-phenyl-pent-1-enyl)-cyclopentyl]-hept-5-enoic acid. This compound is commonly referred to as “bimatoprost acid.” The novel crystalline forms are designated forms I, II, and III. The invention crystalline forms are useful for solid ocular implant formulations, utilized in the treatment of various ocular conditions, such as, for example, ocular hypertension. In addition, invention crystalline forms are useful for solid or semisolid dosage formulations used to treat ocular hypertension.

Abstract: A surgical technique and device wherein an indwelling tube is placed in the eye of a patient having glaucoma. The tube diverts aqueous humor from the anterior chamber to the suprachoroidal space from which it is removed by blood flowing in the choroidal and uveal tissues. This decreases the intraocular pressure.

Abstract: A retinal prosthesis system according to an embodiment includes a converter, a retinal prosthesis, and a transmitter. The converter is placed in an eye, and transmits part of light incident on the eye therethrough while converting the energy of the other part of the light into electrical energy. The retinal prosthesis is placed in the eye and includes a photoelectric conversion element array configured to operate with the electrical energy received from the converter to detect the light having transmitted through the converter to generate an electrical signal. The transmitter is used to send the electrical signal generated by the retinal prosthesis to the visual cortex of the brain.

Abstract: The invention relates to an implant for reducing ocular hypertension. Said implant can be used in particular to prevent and treat glaucomas that are emerging or occur. In particular, the implant is an implant (10) for the Schlemm's canal, which comprises a bridge (20), which has a first end point (22) and a second end point (24) and a first support region (26), a second support region (28), and a connecting piece (30), the bridge (20) extending along a first line (L1) from the first end point (22) to the second end point (24) across the first support region (26), the connecting piece (30), and the second support region (28) and the connecting piece (30) having a first cross-sectional area on average along the first line (L1) and the first support region (26) having a second cross-sectional area on average along the first line (L1) after the implantation, characterized in that the second cross-sectional area is at least 50% larger than the first cross-sectional area.

Abstract: A reading enhancement device for preventing and/or treating presbyopia of the eye. The enhancement device is sutured to an outer wall of the sclera for buckling and compressing a portion of the sclera and the ciliary body inwardly and perpendicular to the plane of the sclera and exerting a posterior compression force toward the vitreous humor in the rear of the eye. The enhancement device includes a compression body with a front of the body having semi-circular convex surface. The convex surface is used for engaging, buckling and compressing both a portion of the sclera and the ciliary body of the eye. The compression body also includes an enlarged, rounded first and second end portions and an elongated center portion with the convex surface formed thereon. Also, the compression body includes a rear having an outwardly extending rib portion with a pair of grooves at opposite ends of the rib portion.

Abstract: Implantable occlusion devices that include one or more flanges extending from a tubular body are disclosed. The flange or flanges may assist in retention of the device within a vessel, cavity, appendage, etc. At least one flange on the occlusion device may include a concave surface proximate one end of a body. Because of the shape of the flange, e.g., its concavity, the occlusion device may resist dislocation due to e.g., the forces generated within the left atrial appendage during atrial fibrillation.

Abstract: A scleral prosthesis includes an elongated body configured to be implanted into scleral tissue of an eye. The body includes (i) opposing first and second free ends and (ii) multiple first portions that form the first end of the body and part of a remainder of the body between the ends. The first portions are separated along at least about half of a total length of the body by empty space such that the first portions meet at a point between the ends and are not connected to each other between that point and the first end. The ends are wider than the remainder. The scleral prosthesis also includes an insert configured to be placed between the first portions and to substantially fill the empty space. The body includes a convex upper surface extending lengthwise between the ends. The insert includes a convex upper surface extending lengthwise along the insert.

Abstract: A scleral prosthesis includes an elongated body configured to be implanted into scleral tissue of an eye. The elongated body includes (i) opposing first and second free ends and (ii) multiple first portions that form the first end of the body and part of a remainder of the body between the first and second ends. The first and second ends are wider than the remainder of the body. The first portions are separated by empty space such that the first portions meet at a point between the first and second ends and are not connected to each other between that point and the first end. The first end projects beyond one or more sides of the remainder of the body and angles back towards the second end. The second end projects beyond the one or more sides of the remainder of the body and angles back towards the first end.

Abstract: A scleral prosthesis includes an elongated body and an insert. The body includes (i) opposing first and second free ends and (ii) multiple first portions that form the first end and part of a remainder of the body between the ends. The first portions are separated along at least about half of a total length of the body by empty space such that the first portions meet at a point between the ends and are not connected to each other between that point and the first end. The ends are wider than the remainder. The insert is configured to be placed between the first portions and to substantially fill the empty space. The first portions are biased so that they maintain separation from one another without external interference but are configured to be pushed towards each other in order to reduce a width of the first end. The insert, when placed between the first portions, keeps the first portions separated and prevents the first portions from being pushed together and reducing the width of the first end.

Abstract: A scleral prosthesis includes an elongated body configured to be implanted into scleral tissue of an eye. The body includes (i) opposing first and second free ends and (ii) a pair of first portions that form the first end and part of a remainder of the body between the ends. The first portions are separated along at least about half of a total length of the body by empty space such that the first portions meet at a point between the ends and are not connected to each other between that point and the first end. The ends are wider than the remainder. The scleral prosthesis also includes an insert configured to be placed between the first portions and to substantially fill the empty space. The insert, prior to insertion, includes one or more slots. The first portions include one or more ridges configured to engage with the one or more slots of the insert.

Abstract: An IOP control system for treatment of an ocular condition includes a drainage device sized for implantation into the eye of the patient, the drainage device including a fluid flow pathway to allow the flow of fluid from an inlet port to an outlet port. The drainage device also includes a flow system disposed within the drainage device and including a displaceable portion forming a part of the fluid flow pathway, the displaceable portion being displaceable via a magnetic field. An actuation system may be physically separate from the drainage device and may be configured to cooperate with the displaceable portion to displace the displaceable portion via the magnetic field to set free buildup or debris in the flow pathway.

Abstract: Systems and methods involving an intraocular implant with input and/or output electronics are described. In some embodiments, the system includes an intraocular lens having at least one optic operably coupled to a haptic, one or more input electronics on the haptic and/or the optic; and one or more output electronics on the haptic and/or the optic for receiving and/or transmitting data.

Abstract: A method for treating progression of a refractive disorder in a human eye. The method includes the steps of producing a first image on a retina of the human eye and producing a second image to generate a defocus.